Screening compound: InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2

Screening compound: InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2
Screening compound: InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C599-0816

Molecular Formula

C14H16ClN3O (C14 H16 ClN3 O)

Compound Name

1-{[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine

IUPAC name

1-{[3-(4-chlorophenyl)-124-oxadiazol-5-yl]methyl}piperidine

SMILES

Clc(cc1)ccc1-c1noc(CN2CCCCC2)n1

InChI

InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2

InChI Key

ZUFSDFSKQNAXID-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00119149

InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2 in Drug Discovery

Included in Screening Libraries

Antiviral Annotated Library (21441 compounds)

CNS BBB Library (22607 compounds)

CNS MPO Library (28609 compounds)

Fragments Library (11262 compounds)

Human Kinases Annotated Library (2415 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Ion Channels Focused Library (26372 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Nervous system
  • Cardiovascular
Structure:
  • Fragments
Targets:
  • Kinases
  • Ion Channels
Mechanism of action:
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2?
Check Price and Availability of InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C14H16ClN3O/c15-12-6-4-11(5-7-12)14-16-13(19-17-14)10-18-8-2-1-3-9-18/h4-7H,1-3,8-10H2 available by request